ProfileGDS4718 / 201740_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 95% 93% 95% 95% 97% 98% 96% 95% 96% 96% 95% 97% 95% 95% 96% 97% 95% 96% 86% 96% 96% 97% 97% 95% 95% 96% 93% 96% 95% 91% 93% 94% 96% 96% 95% 94% 95% 96% 93% 97% 95% 92% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.973997
GSM549102patient 115, normal, homogenized [OPG study]10.149695
GSM549104patient 119, normal, homogenized [OPG study]9.8060293
GSM549108patient 138, normal, homogenized [OPG study]10.31495
GSM549119patient 077, normal, homogenized [OPG study]10.297495
GSM549133patient 032, cancer, homogenized [OPG study]10.735497
GSM549139patient 042, cancer, homogenized [OPG study]11.182698
GSM549099patient 107, normal, homogenized [OPG study]10.661896
GSM549109patient 139, normal, homogenized [OPG study]10.250895
GSM549110patient 046, normal, homogenized [OPG study]10.699896
GSM549114patient 063, normal, homogenized [OPG study]10.794696
GSM549122patient 082, normal, homogenized [OPG study]10.298595
GSM549134patient 033, cancer, homogenized [OPG study]10.785697
GSM549136patient 036, cancer, homogenized [OPG study]10.215795
GSM549140patient 044, cancer, homogenized [OPG study]10.294495
GSM549111patient 047, normal, homogenized [OPG study]10.702196
GSM549113patient 057, normal, homogenized [OPG study]11.104297
GSM549132patient 031, cancer, homogenized [OPG study]10.230695
GSM549137patient 038, cancer, homogenized [OPG study]10.379196
GSM549142patient 047, cancer, homogenized [OPG study]8.2296986
GSM549100patient 110, normal, homogenized [OPG study]10.675196
GSM549107patient 135, normal, homogenized [OPG study]10.693696
GSM549115patient 068, normal, homogenized [OPG study]10.975197
GSM549116patient 072, normal, homogenized [OPG study]11.089697
GSM549120patient 078, normal, homogenized [OPG study]10.365795
GSM549131patient 030, cancer, homogenized [OPG study]10.332795
GSM549118patient 074, normal, homogenized [OPG study]10.622996
GSM549129patient 027, cancer, homogenized [OPG study]9.5556693
GSM549123patient 088, normal, homogenized [OPG study]10.514896
GSM549124patient 006, cancer, homogenized [OPG study]10.043495
GSM549126patient 015, cancer, homogenized [OPG study]9.364991
GSM549128patient 025, cancer, homogenized [OPG study]9.7895693
GSM549103patient 117, normal, homogenized [OPG study]9.9553394
GSM549117patient 073, normal, homogenized [OPG study]10.651596
GSM549138patient 041, cancer, homogenized [OPG study]10.433396
GSM549141patient 045, cancer, homogenized [OPG study]10.339695
GSM549130patient 028, cancer, homogenized [OPG study]9.9165894
GSM549101patient 111, normal, homogenized [OPG study]10.205495
GSM549105patient 128, normal, homogenized [OPG study]10.586696
GSM549106patient 134, normal, homogenized [OPG study]9.9183193
GSM549112patient 048, normal, homogenized [OPG study]11.000197
GSM549125patient 011, cancer, homogenized [OPG study]10.064895
GSM549127patient 024, cancer, homogenized [OPG study]9.4233892
GSM549135patient 035, cancer, homogenized [OPG study]10.517896